Article Sidebar

PDF
Date Published: 13/11/2022
Abstract Views: 370
Views PDF: 300
DOI: https://doi.org/10.51298/vmj.v519i2.3622
Issue
Vol. 519 No. 2 (2022)
Section
Các bài báo
How to Cite
Vân Trường, C. ., Mạnh Hùng, T. ., & Văn Nam, L. . (2022). CLINICAL AND SUBCLINICAL FEATURES OF VENTILATOR ASSOCIATED PNEUMONIA IN COVID-19 PATIENTS AT THE NATIONAL HOSPITAL FOR TROPICAL DISEASES (from 4 /2021 to 3/2022). Vietnam Medical Journal, 519(2). https://doi.org/10.51298/vmj.v519i2.3622

CLINICAL AND SUBCLINICAL FEATURES OF VENTILATOR ASSOCIATED PNEUMONIA IN COVID-19 PATIENTS AT THE NATIONAL HOSPITAL FOR TROPICAL DISEASES (from 4 /2021 to 3/2022)

Cao Vân Trường1, Thân Mạnh Hùng2,3,, Lê Văn Nam1
1 Vietnam Military Medical University
2 National Hospital for Tropical Diseases
3 University of Medicine and Pharmacy, Vietnam National University, Hanoi

Main Article Content

Abstract

Objectives: describes some subclinical features of ventilator associated pneumonia (VAP) in COVID-19 patients during the 4th outbreak. Participants and methods: a cross-sectional study on 151 VAP patients treated in the National Hospital for Tropical Diseases, collected subclinical variations and characteristics of fungal and bacterial superinfection in COVID-19 of VAP patients. Results: The average white blood value is 11.31±5.36 G/l of which WBC>10G/l accounts for 54.3%; D-dimer ≥500 ng/l accounted for 83.8% with Med (IQR) of 1311 (3101).  Increased PCT,  CRP, and decrease albumin are common in most patients. It is common to increased urea, creatinin and blood glucose. Cause of VAP was fungal and bacterial superinfections accounted for 80.1%, the fungal-caused of VAP accounted for 19.9%.

Article Details

Keywords

COVID-19, mechanical ventilation, superinfection

References

1. Guan W.-j., Ni Z.-y., Hu Y., et al. (2020). Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv,
2. WHO (2022). COVID-19 Weekly Epidemiological Update_97, 23.
3. Bộ Y tế (2022). Bản tin phòng chống dịch COVID-19 ngày 31/7/2022, 3.
4. Meawed T. E., Ahmed S. M., Mowafy S. M. S., et al. (2021). Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. J Infect Public Health, 14 (10), 1375-1380.
5. Blonz G., Kouatchet A., Chudeau N., et al. (2021). Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care, 25 (1), 72.
6. Richards O., Pallmann P., King C., et al. (2021). Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS. Antibiotics (Basel), 10 (11),
7. Pickens C. O., Gao C. A., Cuttica M. J., et al. (2021). Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. Am J Respir Crit Care Med, 204 (8), 921-932.
8. Goyal P., Choi J. J., Pinheiro L. C., et al. (2020). Clinical Characteristics of Covid-19 in New York City. N Engl J Med, 382 (24), 2372-2374.
9. Kalil A. C., Metersky M. L., Klompas M., et al. (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis, 63 (5), e61-e111.
10. Sharifipour E., Shams S., Esmkhani M., et al. (2020). Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis, 20 (1), 646.